First Time Loading...
S

Singular Genomics Systems Inc
NASDAQ:OMIC

Watchlist Manager
Singular Genomics Systems Inc
NASDAQ:OMIC
Watchlist
Price: 0.371 USD -2.37% Market Closed
Updated: May 17, 2024
OMIC
/
Income Statement
/
Cost of Revenue

Singular Genomics Systems Inc
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Singular Genomics Systems Inc
Cost of Revenue Peer Comparison

Comparables:
TMO
DHR
MTD
A
IQV

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
S
Singular Genomics Systems Inc
NASDAQ:OMIC
Cost of Revenue
-$3.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Thermo Fisher Scientific Inc
NYSE:TMO
Cost of Revenue
-$25.8B
CAGR 3-Years
-17%
CAGR 5-Years
-14%
CAGR 10-Years
-13%
Danaher Corp
NYSE:DHR
Cost of Revenue
-$18.2B
CAGR 3-Years
-20%
CAGR 5-Years
-20%
CAGR 10-Years
-7%
Mettler-Toledo International Inc
NYSE:MTD
Cost of Revenue
-$1.5B
CAGR 3-Years
-5%
CAGR 5-Years
-4%
CAGR 10-Years
-3%
Agilent Technologies Inc
NYSE:A
Cost of Revenue
-$3.3B
CAGR 3-Years
-9%
CAGR 5-Years
-8%
CAGR 10-Years
-7%
IQVIA Holdings Inc
NYSE:IQV
Cost of Revenue
-$9.7B
CAGR 3-Years
-9%
CAGR 5-Years
-8%
CAGR 10-Years
-10%

See Also

What is Singular Genomics Systems Inc's Cost of Revenue?
Cost of Revenue
-3.5m USD

Based on the financial report for Dec 31, 2023, Singular Genomics Systems Inc's Cost of Revenue amounts to -3.5m USD.

What is Singular Genomics Systems Inc's Cost of Revenue growth rate?
Cost of Revenue CAGR 1Y
-339%

Over the last year, the Cost of Revenue growth was -339%.

ALPHA SPREAD
Join more than 138,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.